| Key Financial Ratios of Natco Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
103.31 |
72.79 |
34.90 |
7.63 |
16.99 |
|
| Diluted EPS (Rs.) |
103.31 |
72.79 |
34.90 |
7.63 |
16.96 |
|
| Cash EPS (Rs.) |
115.66 |
82.60 |
43.18 |
15.21 |
23.27 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
409.72 |
312.42 |
257.64 |
229.69 |
224.17 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
409.72 |
312.42 |
257.64 |
229.69 |
224.17 |
|
| Dividend / Share(Rs.) |
6.00 |
9.50 |
5.50 |
4.50 |
5.25 |
|
| Revenue from Operations/Share (Rs.) |
228.74 |
199.38 |
128.82 |
96.87 |
90.60 |
|
| PBDIT/Share (Rs.) |
137.74 |
97.30 |
50.97 |
16.85 |
28.42 |
|
| PBIT/Share (Rs.) |
125.45 |
87.70 |
42.70 |
9.27 |
22.11 |
|
| PBT/Share (Rs.) |
124.36 |
86.89 |
42.23 |
8.54 |
21.49 |
|
| Net Profit/Share (Rs.) |
103.37 |
72.99 |
34.91 |
7.62 |
16.96 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
60.21 |
48.80 |
39.56 |
17.40 |
31.36 |
|
| PBIT Margin (%) |
54.84 |
43.98 |
33.14 |
9.57 |
24.40 |
|
| PBT Margin (%) |
54.36 |
43.57 |
32.78 |
8.81 |
23.71 |
|
| Net Profit Margin (%) |
45.19 |
36.61 |
27.09 |
7.86 |
18.71 |
|
| Return on Networth / Equity (%) |
25.23 |
23.36 |
13.54 |
3.31 |
7.56 |
|
| Return on Capital Employed (%) |
30.32 |
27.69 |
16.17 |
3.91 |
9.52 |
|
| Return on Assets (%) |
22.37 |
19.93 |
11.82 |
2.79 |
6.51 |
|
| Total Debt/Equity (X) |
0.04 |
0.06 |
0.03 |
0.09 |
0.06 |
|
| Asset Turnover Ratio (%) |
0.55 |
0.60 |
0.45 |
0.36 |
0.35 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
5.42 |
3.85 |
4.38 |
3.34 |
4.17 |
|
| Quick Ratio (X) |
4.68 |
3.18 |
3.30 |
2.27 |
2.68 |
|
| Inventory Turnover Ratio (X) |
6.61 |
0.86 |
0.72 |
0.71 |
0.58 |
|
| Dividend Payout Ratio (NP) (%) |
5.80 |
13.02 |
15.75 |
59.02 |
36.80 |
|
| Dividend Payout Ratio (CP) (%) |
5.19 |
11.51 |
12.74 |
29.58 |
26.81 |
|
| Earnings Retention Ratio (%) |
94.20 |
86.98 |
84.25 |
40.98 |
63.20 |
|
| Cash Earnings Retention Ratio (%) |
94.81 |
88.49 |
87.26 |
70.42 |
73.19 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
12,695.03 |
16,530.15 |
10,034.51 |
14,108.83 |
15,051.29 |
|
| EV/Net Operating Revenue (X) |
3.10 |
4.63 |
4.27 |
7.98 |
9.10 |
|
| EV/EBITDA (X) |
5.15 |
9.49 |
10.79 |
45.87 |
29.02 |
|
| MarketCap/Net Operating Revenue (X) |
3.49 |
4.77 |
4.38 |
7.82 |
9.11 |
|
| Retention Ratios (%) |
94.19 |
86.97 |
84.24 |
40.97 |
63.19 |
|
| Price/BV (X) |
1.95 |
3.05 |
2.19 |
3.30 |
3.68 |
|
| Price/Net Operating Revenue |
3.49 |
4.77 |
4.38 |
7.82 |
9.11 |
|
| Earnings Yield |
0.13 |
0.08 |
0.06 |
0.01 |
0.02 |
|
Source : Dion Global Solutions Limited
